Prostate Cancer Survivorship: Prevention and Treatment of the Adverse Effects of Androgen Deprivation Therapy

被引：0
作者：
Philip J. Saylor
Nancy L. Keating
Matthew R. Smith
机构：
[1] Massachusetts General Hospital Cancer Center,Division of Hematology
[2] Harvard Medical School,Oncology
来源：
Journal of General Internal Medicine | 2009年 / 24卷
关键词：
prostate cancer; survivorship; GnRH agonists; osteoporosis; bisphosphonates; diabetes; obesity; cardiovascular disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：389 / 394
页数：5
相关论文
共 50 条
  • [41] Metabolic impact of androgen deprivation therapy for prostate cancer
    Andres, E.
    Eschwege, P.
    Lang, H.
    Moreau, J. -L.
    Peiffert, D.
    Thiery-Vuillemin, A.
    Kleinclauss, F.
    PROGRES EN UROLOGIE, 2012, 22 : S39 - S47
  • [42] Cardiovascular Risks of Androgen Deprivation Therapy for Prostate Cancer
    Corona, Giovanni
    Filippi, Sandra
    Bianchi, Nicola
    Dicuio, Mauro
    Rastrelli, Giulia
    Concetti, Sergio
    Sforza, Alessandra
    Maggi, Mario
    WORLD JOURNAL OF MENS HEALTH, 2021, 39 (03) : 429 - 443
  • [43] Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
    Nguyen, Paul L.
    Alibhai, Shabbir M. H.
    Basaria, Shehzad
    D'Amico, Anthony V.
    Kantoff, Philip W.
    Keating, Nancy L.
    Penson, David F.
    Rosario, Derek J.
    Tombal, Bertrand
    Smith, Matthew R.
    EUROPEAN UROLOGY, 2015, 67 (05) : 825 - 836
  • [44] The Adverse Effects of Androgen Deprivation Therapy in Prostate Cancer and the Benefits and Potential Anti-oncogenic Mechanisms of Progressive Resistance Training
    Lam, Teresa
    Birzniece, Vita
    McLean, Mark
    Gurney, Howard
    Hayden, Amy
    Cheema, Birinder S.
    SPORTS MEDICINE-OPEN, 2020, 6 (01)
  • [45] miRNAs and androgen deprivation therapy for prostate cancer
    Konoshenko, Maria Yu
    Bryzgunova, Olga E.
    Laktionov, Pavel P.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (02):
  • [46] Dose-dependent effect of androgen deprivation therapy for localized prostate cancer on adverse cardiac events
    Schmid, Marianne
    Sammon, Jesse D.
    Reznor, Gally
    Kapoor, Victor
    Speed, Jacqueline M.
    Abdollah, Firas A.
    Sood, Akshay
    Chun, Felix K. -H.
    Kibel, Adam S.
    Menon, Mani
    Fisch, Margit
    Sun, Maxine
    Trinh, Quoc-Dien
    BJU INTERNATIONAL, 2016, 118 (02) : 221 - 229
  • [47] Intermittent androgen deprivation therapy for prostate cancer
    Rashid, MH
    Chaudhary, UB
    ONCOLOGIST, 2004, 9 (03) : 295 - 301
  • [48] Prostate cancer treatment and the relationship of androgen deprivation therapy to cognitive function
    A. B. Reiss
    U. Saeedullah
    D. J. Grossfeld
    A. D. Glass
    A. Pinkhasov
    A. E. Katz
    Clinical and Translational Oncology, 2022, 24 : 733 - 741
  • [49] Advances with androgen deprivation therapy for prostate cancer
    Yu, Eun-mi
    Aragon-Ching, Jeanny B.
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (09) : 1015 - 1033
  • [50] Prostate cancer treatment and the relationship of androgen deprivation therapy to cognitive function
    Reiss, A. B.
    Saeedullah, U.
    Grossfeld, D. J.
    Glass, A. D.
    Pinkhasov, A.
    Katz, A. E.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (05) : 733 - 741
12345